Matilde Coriano

Parma, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

RAD51-based homologous recombination deficiency is associated with treatment response and survival in early breast cancer.

RAD51-based homologous recombination deficiency is associated with treatment response and survival in early breast cancer.

Journal: NPJ breast cancer
Published: July 31, 2025

SARS-CoV-2 Infection Risk and COVID-19 Prevalence and Mortality in Cancer Patients During the First Wave of COVID-19 Pandemic in a Virus Epicenter in Northern Italy.

SARS-CoV-2 Infection Risk and COVID-19 Prevalence and Mortality in Cancer Patients During the First Wave of COVID-19 Pandemic in a Virus Epicenter in Northern Italy.

Journal: Cancers
Published: March 13, 2025

Role of Hb to RDW ratio in metastatic renal cell carcinoma patients treated with first-line immunotherapy combinations.

Role of Hb to RDW ratio in metastatic renal cell carcinoma patients treated with first-line immunotherapy combinations.

Journal: Immunotherapy
Published: January 20, 2025

Differential impact of lipid profile according to neutrophil-to-lymphocyte ratio status in patients with advanced cancer treated with immunotherapy.

Differential impact of lipid profile according to neutrophil-to-lymphocyte ratio status in patients with advanced cancer treated with immunotherapy.

Journal: Immunotherapy
Published: August 06, 2024

The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective study.

The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective study.

Journal: Breast cancer research and treatment
Published: March 10, 2024

Hormone Receptor-Positive/HER2-Positive Breast Cancer: Hormone Therapy and Anti-HER2 Treatment: An Update on Treatment Strategies.

Hormone Receptor-Positive/HER2-Positive Breast Cancer: Hormone Therapy and Anti-HER2 Treatment: An Update on Treatment Strategies.

Journal: Journal of clinical medicine
Published: February 20, 2024

Functional HRD by RAD51 identifies BRCA1 VUS associated with loss of gene function and response to DNA-damaging agents.

Functional HRD by RAD51 identifies BRCA1 VUS associated with loss of gene function and response to DNA-damaging agents.

Journal: ESMO open
Published: February 12, 2024

Social Determinants of Health and Cardiac Risk for Patients With Breast Cancer: Beyond Racial Disparities.

Social Determinants of Health and Cardiac Risk for Patients With Breast Cancer: Beyond Racial Disparities.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: July 11, 2023

Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome?

Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome?

Journal: Expert review of anticancer therapy
Published: April 05, 2023

Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario.

Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario.

Journal: Technology in cancer research & treatment
Published: March 01, 2023

Long-Term Effects of Breast Cancer Therapy and Care: Calm after the Storm?

Long-Term Effects of Breast Cancer Therapy and Care: Calm after the Storm?

Journal: Journal of clinical medicine
Published: October 28, 2022

Should patients on levothyroxine therapy be screened for pancreatic cancer?

Should patients on levothyroxine therapy be screened for pancreatic cancer?

Journal: Acta bio-medica : Atenei Parmensis
Published: June 19, 2022
Showing 1-12 of 16

Last Updated: 09/26/2026